HIV Diagnosis Market by Test Type (Antibody (ELISA, Rapid, Western Blot), Viral Load, CD4 Count, Early Infant, Viral Identification, Product (Assay, Kit, Reagent, Instrument, Software, Services), End User (Hospitals) - Global Forecast to 2021
[137 Pages Report] The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021. Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.
Market Dynamics
Drivers
- Growing Worldwide Prevalence of HIV/Aids
- Increasing Number of Blood Transfusions and Blood Donations
- Benefits Offered By Point-Of-Care Instruments & Kits
- Increasing Government Initiatives
Restraint
- High Cost of Nat
- Lack of Mandates for Nat in Developing Countries
Opportunities
- Emerging Economies Offer Lucrative Growth Opportunities for HIV Diagnosis
Trends
- Increase in Use of Home Access Kits and Instruments
The objectives of this study are as follows:
- To define, describe, and forecast the global HIV diagnosis market by product, test type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as product launches, agreements, expansions, acquisitions, and other developments in the global HIV diagnosis market
Research Methodology
Top-down and bottom-up approaches were used to estimate and validate the size of the global HIV diagnosis market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation-by products and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
Various secondary sources referred to for this research study include publications from government sources such as the white papers; articles from recognized authors; gold standard and silver standard websites, directories, and databases; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations have been used to identify and collect information useful for this extensive commercial study of the HIV diagnosis market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the HIV diagnosis market. The breakdown of profiles of primaries is shown in the figure below:
To know about the assumptions considered for the study, download the pdf brochure
The major players in the HIV diagnosis market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo-Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Hologic, Inc. (US), Alere Inc. (US), and Bio-Rad Laboratories (US).
Target Audience for this Report:
- Manufacturers of HIV Diagnosis Products
- Vendors and Distributors of Powered Surgical Instruments
- Hospitals
- Research Institutes Related to HIV/AIDS Studies
- Venture Capitalists and Investors
Value Addition for the Buyer:
This report provides insights into the global HIV diagnosis market. It provides valuable information on the products, test type, and regions in the HIV diagnosis market. The geographic analysis for these segments is also presented in this report. Leading players in the market are profiled to study their device offerings and understand strategies undertaken by them to be competitive in this market.
The above-mentioned information would help the buyer understand market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities.
Major Market Developments
- In March 2014, Siemens released a software upgrade for the RAPIDComm Data Management System, a solution to centrally manage Siemens’ In Vitro Diagnostics analyzers and operators at the point-of-care.
- In December 2016, Siemens Healthineers invested USD 300 million in its Walpole, Massachusetts facility to manufacture ADVIA Centaur family of Immunoassay instruments.
- In June 2016, Roche launched Cobas e 801 module which offers more than 100 immunoassays and a wide range of disease diagnostics.
- In May 2015, Thermo Fisher launched iBind Flex Western device, working on the western blot technique for detection of infection.
Critical questions the report answers
- How the market developments of key players impact the overall industry?
- What are the restraining factors for this market?
AIDS is a major public health concern with a prevalence rate that has increased dramatically in the past two decades. This increase in the prevalence of HIV, and the subsequent increase in the number of patients suffering from AIDS, has resulted in an increase in the demand for advanced technologies for HIV diagnostics.
According to the World Health Organization (WHO), in 2016, around 36 million people were diagnosed with HIV globally, of which 2.1 million were reported to be cases of new HIV infections. Globally, 1.1 million people died from HIV-related causes in 2015. According to the CDC, in 2015, more than 1.2 million people in the U.S. were reportedly infected with HIV, and almost 19% of these were not aware about their status. According to Canada’s source for HIV, the CATIE, in 2014, 75,500 Canadians were found to be HIV-infected, and HIV incidence has increased by 9.7% since 2011. According to the Robert Koch Institute, there were 84,700 individuals with HIV in Germany in 2016 and more than 3,200 new cases of HIV in 2015. According to AVERT, in 2015, 5.1 million people were living with HIV/AIDS in Asia, of which only 64% population were aware about their HIV status. In the same year, 180,000 people died of AIDS in Asia.
This increasing prevalence of HIV across the globe will result in an increased need for diagnostic and testing procedures, which in turn will boost the HIV diagnostics market growth.
Want to explore hidden markets that can drive new revenue in HIV Diagnosis Market?
Scope of the Report:
Want to explore hidden markets that can drive new revenue in HIV Diagnosis Market?
This report categorizes the HIV diagnostics market into the following segments:
HIV Diagnostics Market, By Product
-
Consumables
- Assays and Kits & Reagents
- Other Consumables
- Instruments
- Software & Services
HIV Diagnostics Market, By Test Type
-
Antibody Tests
-
HIV-1 Screening Tests
- ELISA
- Rapid Tests
- Home Access Dried Blood Spot
-
HIV-1 Confirmatory Tests
- Western Blot Tests
- Indirect Immune Fluorescent Antibody Assays (IFA)
- Line Immunoassays (LIA)
- Radio-Immunoprecipitation Assays (RIPA)
- HIV-2 & Group O Diagnostic Tests
-
HIV-1 Screening Tests
- Viral Load Tests
- CD4 Tests
- Tests for Early Infant Diagnosis
- Tests for Viral Identification
HIV Diagnostics Market, By End User
- Diagnostic Laboratories
- Hospitals
- Blood Banks
- Home Care Settings
- Other End Users
HIV Diagnostics Market, by Region
-
North America
- US
- Canada
- Europe
-
Asia
- China
- Japan
- India
- RoA
- Rest of the World (RoW)
Customization Options:
- Company Information: Detailed company profiles of five or more market players
- Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market.
The HIV diagnosis market is projected to reach USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016, at a CAGR of 10.5% from 2016 to 2021. Factors such as the growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide.
This market is segmented based on products, test types, end user, and region. On the basis of product, the market is segmented into consumables (assays, kits, reagents, and other consumables), instruments, and software and services. In 2016, the consumables segment is expected to account for the largest share of the market. The frequent and repetitive purchase of consumables by laboratories and hospitals, growing prevalence of HIV/AIDS, and increasing initiatives from governments to fight HIV/AIDS are some of the major factors driving the consumables market.
On the basis of test type, the market is segmented into antibody tests, viral load tests, CD4 count tests, tests for early infant diagnosis, and tests for viral identification. The antibody tests segment is further divided into HIV-1 screening tests, HIV-1 confirmatory tests, and HIV-2 and group O diagnostic tests. The antibody tests segment is expected to account for the largest share of the market in 2016. This large share can be attributed to the increasing technological advancements in HIV diagnosis, growing awareness about HIV, and rising blood donations.
On the basis of end user, the HIV diagnosis market is divided into diagnostic laboratories, hospitals, blood banks, home care settings, and others (gene banks, cell banks, biotechnology and pharmaceutical companies, and academic research institutes). The diagnostic laboratories segment is expected to account for the largest share of market in 2016. This large share is mainly due to high investment and technological advancements of diagnostics laboratories. It is also driven by increasing awareness of HIV/AIDS.
The global HIV diagnosis market is segmented into four major regions—North America, Europe, Asia, and Rest of the World. Geographically, the market is dominated by North America. Growth in the North American segment is primarily driven by the high incidence and prevalence of HIV/AIDS, increasing awareness about HIV/AIDS, and growing government initiatives and increasing blood donations.
Benefits Offered By Point-Of-Care Instruments Will Boost the Growth of This Market
Point-of-care (PoC) HIV tests are also known as rapid HIV tests. In regular practice, HIV diagnosis includes pre-test counselling, HIV testing, and post-test counselling wherein patients are required to return for test results at later dates. In PoC HIV diagnosis, counselling and screening are carried out simultaneously while the patient is still in the lab. This is followed by confirmatory tests, if needed. Since pre-test and post-test counselling are carried out at the same in PoC tests, individuals are not required to return for their results, making it a very convenient option.
Rapid HIV tests provide results in less than 30 minutes, eliminating the stress of waiting for results. These tests detect antibodies in the serum/blood but the detection window is 3–4 weeks. Rapid HIV testing mainly targets undiagnosed cases for HIV as well as those who have not returned for follow-up testing. As a result of their various advantages, the demand for technologically advanced PoC kits and instruments is on the rise, which is expected to aid in the growth of the HIV diagnostics market in the coming years.
Key players in the HIV Diagnosis Market are Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo-Fisher Scientific Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Hologic, Inc. (US), Alere Inc. (US), and Bio-Rad Laboratories (US).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Table of Contents
1 Introduction (Page No. - 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 17)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 25)
3.1 Introduction
3.2 Conclusion
4 Premium Insights (Page No. - 28)
4.1 HIV Diagnosis: Market Overview
4.2 Geographic Analysis: HIV Diagnosis Market, By Test Type (2016)
4.3 Geographic Snapshot of the Market
4.4 Life Cycle Analysis, By Region
5 Market Overview (Page No. - 32)
5.1 Introduction
5.1.1 Drivers
5.1.1.1 Growing Worldwide Prevalence of HIV/Aids
5.1.1.2 Increasing Number of Blood Transfusions and Blood Donations
5.1.1.3 Benefits Offered By Point-Of-Care Instruments & Kits
5.1.1.4 Increasing Government Initiatives
5.1.2 Restraints
5.1.2.1 High Cost of Nat
5.1.2.2 Lack of Mandates for Nat in Developing Countries
5.1.3 Opportunity
5.1.3.1 Emerging Economies Offer Lucrative Growth Opportunities for HIV Diagnosis
5.1.4 Trend
5.1.4.1 Increase in Use of Home Access Kits and Instruments
6 HIV Diagnosis Market, By Product (Page No. - 39)
6.1 Introduction
6.2 Consumables
6.2.1 Assays and Kits & Reagents
6.2.2 Other Consumables
6.3 Instruments
6.4 Software & Services
7 HIV Diagnosis Market, By Test Type (Page No. - 47)
7.1 Introduction
7.2 Antibody Tests
7.2.1 HIV-1 Screening Tests
7.2.1.1 Elisa
7.2.1.2 Rapid Tests
7.2.1.3 Home Access Dried Blood Spots
7.2.2 HIV-1 Antibody Confirmatory Tests
7.2.2.1 Western Blot Tests
7.2.2.2 Indirect Immunofluorescence Assays (IFA)
7.2.2.3 Line Immunoassays
7.2.2.4 Radio-Immunoprecipitation Assays
7.2.3 HIV-2 & Group O Diagnostic Tests
7.3 Viral Load Tests
7.4 CD4 Tests
7.5 Tests for Early Infant Diagnosis
7.6 Tests for Viral Identification
8 HIV Diagnosis Market, By End User (Page No. - 64)
8.1 Introduction
8.2 Diagnostic Laboratories
8.3 Hospitals
8.4 Blood Banks
8.5 Home Care Settings
8.6 Other End Users
9 HIV Diagnosis Market, By Region (Page No. - 71)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia (RoA)
9.5 Rest of the World (RoW)
10 Competitive Landscape (Page No. - 98)
10.1 Introduction
10.2 Strategic Overview
10.3 Market Share Analysis
10.4 Competitive Situation and Trends
10.4.1 Product Launches
10.4.2 Agreements, Partnerships & Collaborations
10.4.3 Expansions
10.4.4 Other Developments
11 Company Profiles (Page No. - 104)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Siemens Healthineers (A Division of Siemens AG)
11.3 Roche Diagnostics (Division of Hoffman La Roche Ltd.)
11.4 Abbott Laboratories
11.5 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
11.6 Thermo-Fisher Scientific Inc.
11.7 Merck KGaA
11.8 Becton, Dickinson & Company
11.9 Hologic Inc.
11.10 Alere Inc.
11.11 Bio-Rad Laboratories
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 129)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
List of Tables (72 Tables)
Table 1 Global HIV Prevalence, 2015
Table 2 Global HIV Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 3 Global HIV Diagnostics Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 4 Global HIV Diagnostics Market Size for Consumables, By Region, 2014–2021 (USD Million)
Table 5 Global HIV Diagnostics Market Size for Assays and Kits & Reagents, By Region, 2014–2021 (USD Million)
Table 6 Global Market Size for Other Consumables, By Region, 2014–2021 (USD Million)
Table 7 Global Market Size for Instruments, By Region, 2014–2021 (USD Million)
Table 8 Global Market Size for Software & Services, By Region, 2014–2021 (USD Million)
Table 9 Market Size, By Type of Test, 2014–2021 (USD Million)
Table 10 Market Size for Antibody Tests, By Type, 2014–2021 (USD Million)
Table 11 Market Size for Antibody Tests, By Region, 2014–2021 (USD Million)
Table 12 HIV-1 Screening Tests Market Size, By Type, 2014–2021 (USD Million)
Table 13 HIV-1 Screening Tests Market Size, By Region, 2014–2021 (USD Million)
Table 14 HIV-1 Screening Tests Market Size for Elisa, By Region, 2014–2021 (USD Million)
Table 15 HIV-1 Screening Tests Market Size for Rapid Tests, By Region, 2014–2021 (USD Million)
Table 16 HIV-1 Screening Tests Market Size for Home Access Dried Blood Spots, By Region, 2014–2021 (USD Million)
Table 17 HIV-1 Antibody Confirmatory Tests Market Size, By Type, 2014–2021 (USD Million)
Table 18 HIV-1 Antibody Confirmatory Tests Market Size, By Region, 2014–2021 (USD Million)
Table 19 HIV-1 Antibody Confirmatory Tests Market Size for Western Blot Tests, By Region, 2014–2021 (USD Million)
Table 20 HIV-1 Antibody Confirmatory Tests Market Size for Indirect IFA, By Region, 2014–2021 (USD Million)
Table 21 HIV-1 Antibody Confirmatory Tests Market Size for Line Immunoassays, By Region, 2014–2021 (USD Million)
Table 22 HIV-1 Antibody Confirmatory Tests Market Size for Radio-Immunoprecipitation Assays, By Region, 2014–2021 (USD Million)
Table 23 HIV-2 & Group O Diagnostic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 24 HIV Diagnostics Market Size for Viral Load Tests, By Region, 2014–2021 (USD Million)
Table 25 HIV Diagnostics Market Size for CD4 Tests, By Region, 2014–2021 (USD Million)
Table 26 HIV Diagnostics Market Size for Tests for Early Infant Diagnosis, By Region, 2014–2021 (USD Million)
Table 27 HIV Diagnostics Market Size for Tests for Viral Identification, By Region, 2014–2021 (USD Million)
Table 28 HIV Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 29 Global HIV Diagnostics Market Size for Diagnostic Laboratories, By Region, 2014–2021 (USD Million)
Table 30 Global HIV Diagnostics Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 31 Global HIV Diagnostics Market Size for Blood Banks, By Region, 2014–2021 (USD Million)
Table 32 Global HIV Diagnostics Market Size for Home Care Settings, By Region, 2014–2021 (USD Million)
Table 33 Global HIV Diagnostics Market Size for Other End Users, By Region, 2014–2021 (USD Million
Table 34 Global HIV Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 35 North America: HIV Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 36 North America: HIV Diagnostics Market Size, By Test Type, 2014–2021 (USD Million)
Table 37 North America: HIV Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 38 North America: HIV Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 39 U.S.: HIV Diagnosis Market Size, By Test Type, 2014–2021 (USD Million)
Table 40 U.S.: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 41 U.S.: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 42 Canada: HIV Diagnosis Market Size, By Test Type, 2014–2021 (USD Million)
Table 43 Canada: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 44 Canada: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 45 Number of HIV Tests in Europe, By Country, 2014
Table 46 Europe: HIV Diagnosis Market Size, By Test Type, 2014–2021 (USD Million)
Table 47 Europe: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 48 Europe: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 49 Asia: HIV Diagnosis Market Size, By Country, 2014–2021 (USD Million)
Table 50 Asia: HIV Diagnosis Market Size, By Test Type, 2014–2021 (USD Million)
Table 51 Asia: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 52 Asia: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 53 China: HIV Diagnosis Market Size, By Test Type, 2014–2021 (USD Million)
Table 54 China: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 55 China: HIV Diagnosis Market Size, By End User, 2014–2021 (USD Million)
Table 56 Japan: HIV Diagnosis Market Size, By Test Type, 2014–2021 (USD Million)
Table 57 Japan: HIV Diagnosis Market Size, By Product, 2014–2021 (USD Million)
Table 58 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 59 India: Market Size, By Test Type, 2014–2021 (USD Million)
Table 60 India: Market Size, By Product, 2014–2021 (USD Million)
Table 61 India: Market Size, By End User, 2014–2021 (USD Million)
Table 62 RoA: Market Size, By Test Type, 2014–2021 (USD Million)
Table 63 RoA: HIV Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 64 RoA: HIV Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 65 RoW: HIV Diagnostics Market Size, By Test Type, 2014–2021 (USD Million)
Table 66 RoW: HIV Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 67 RoW: HIV Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 68 Growth Strategy Matrix, 2014–2016
Table 69 Product Launches, 2014–2016
Table 70 Agreements, Partnerships, & Collaborations, 2014–2016
Table 71 Expansions, 2014–2016
Table 72 Other Developments, 2014–2016
List of Figures (53 Figures)
Figure 1 Global HIV Diagnostics Market Segmentation
Figure 2 HIV Diagnostics Market: Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 HIV Diagnostics Market: Bottom-Up Approach
Figure 5 HIV Diagnostics Market: Top-Down Approach
Figure 6 HIV Diagnostics Market: Data Triangulation Methodology
Figure 7 Global HIV Diagnostics Market Size, By Product, 2016 vs 2021 (USD Million)
Figure 8 Global HIV Diagnostics Market Size, By Test Type, 2016 vs 2021 (USD Million)
Figure 9 Global HIV Diagnostics Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 10 Geographical Snapshot of the HIV Diagnostics Market
Figure 11 Global HIV Diagnostics Market to Witness Moderate Growth During the Forecast Period
Figure 12 Antibody Tests Segment Commanded the Largest Share of the Global HIV Diagnostics Market in 2016
Figure 13 Asia Projected to Register the Highest CAGR During the Forecast Period
Figure 14 Asian Market Showcases Lucrative Growth Opportunities
Figure 15 HIV Diagnostics Market: Drivers, Restraints, Opportunities, and Trends
Figure 16 HIV Diagnostics Market Segmentation, By Product
Figure 17 Consumables Were the Largest Product Segment in the HIV Diagnostics Market in 2016
Figure 18 Assays and Kits & Reagents Were the Largest Product Segment in 2016
Figure 19 HIV Diagnostics Market Segmentation, By Test Type
Figure 20 Antibody Tests Were the Largest Test Segment in the HIV Diagnostics Market in 2016
Figure 21 HIV-1 Screening Tests Dominated the HIV Diagnostics Market for Antibody Tests in 2016
Figure 22 Elisa Was the Largest HIV-1 Screening Tests Segment in 2016
Figure 23 Western Blot Tests Were the Largest Segment in the HIV-1 Antibody Confirmatory Tests Market in 2016
Figure 24 Diagnostic Laboratories Commanded the Largest Market Share in 2016
Figure 25 Geographic Snapshot: Emerging Markets in Asia Offer Significant Growth Opportunities in the HIV Diagnosis Market
Figure 26 HIV Diagnosis Market in Asia to Register the Highest CAGR During Forecast Period
Figure 27 North America: HIV Diagnosis Market Snapshot
Figure 28 U.S. to Dominate the North American HIV Diagnosis Market During the Forecast Period
Figure 29 Antibody Tests Dominated the North American HIV Diagnosis Market, By Test Type, in 2016
Figure 30 Viral Load Tests Segment to Register the Highest CAGR in the U.S. HIV Diagnosis Market
Figure 31 Antibody Tests Form the Largest Segment in the Canadian HIV Diagnosis Market in 2016
Figure 32 Market for Viral Load Tests in Europe to Register the Highest Growth During the Forecast Period
Figure 33 China Dominated the Asian HIV Diagnosis Market in 2016
Figure 34 Asia: HIV Diagnosis Market Snapshot
Figure 35 Antibody Tests Accounted for the Largest Share of the Asian HIV Diagnostics Market in 2016
Figure 36 Antibody Tests Accounted for the Largest Share of the HIV Diagnostics Market in China in 2016
Figure 37 Antibody Tests Held the Largest Share of the Japanese HIV Diagnostics Market in 2016
Figure 38 Antibody Tests Accounted for the Largest Share of the Indian HIV Diagnostics Market in 2016
Figure 39 Antibody Tests Held the Largest Share of the RoA HIV Diagnostics Market in 2016
Figure 40 Antibody Tests Held the Largest Share of the RoW HIV Diagnostics Market in 2016
Figure 41 Product Launch Was the Key Strategy Adopted By Players in the HIV Diagnosis Market
Figure 42 HIV Diagnosis Market Share Analysis, By Key Player, 2015
Figure 43 Geographic Revenue Mix of the Top Six Market Players
Figure 44 Siemens AG: Company Snapshot (2016)
Figure 45 Roche Diagnostics: Company Snapshot (2015)
Figure 46 Abbott Laboratories: Company Snapshot (2015)
Figure 47 Danaher Corporation: Company Snapshot (2015)
Figure 48 Thermo-Fisher Scientific Inc.: Company Snapshot (2015)
Figure 49 Merck KGaA: Company Snapshot (2015)
Figure 50 Becton, Dickinson & Company.: Company Snapshot (2016)
Figure 51 Hologic Inc.: Company Snapshot (2016)
Figure 52 Alere Inc: Company Snapshot (2016)
Figure 53 Bio-Rad Laboratories: Company Snapshot (2015)
Generating Response ...
Growth opportunities and latent adjacency in HIV Diagnosis Market